Conduit Pharmaceuticals Inc (NASDAQ:CDT) has a beta value of 2.24 and has seen 56.44 million shares traded in the last trading session. The company, currently valued at $14.03M, closed the last trade at $0.19 per share which meant it gained $0.02 on the day or 11.76% during that session. The CDT stock price is -13057.89% off its 52-week high price of $25.00 and 15.79% above the 52-week low of $0.16. If we look at the company’s 10-day average daily trading volume, we find that it stood at 40.93 million shares traded. The 3-month trading volume is 8.37 million shares.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Sporting 11.76% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CDT stock price touched $0.19 or saw a rise of 54.22%. Year-to-date, Conduit Pharmaceuticals Inc shares have moved -95.82%, while the 5-day performance has seen it change -5.38%. Over the past 30 days, the shares of Conduit Pharmaceuticals Inc (NASDAQ:CDT) have changed -34.48%. Short interest in the company has seen 0.62 million shares shorted with days to cover at 0.35.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Insiders own 86.65% of the company shares, while shares held by institutions stand at 2.90% with a share float percentage of 21.72%. Investors are also buoyed by the number of investors in a company, with Conduit Pharmaceuticals Inc having a total of 28.0 institutions that hold shares in the company.
